We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PLSE market cap is 709.94M. The company's latest EPS is USD -0.7676 and P/E is -16.35.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -9.56M | -10.23M | -11.25M | -12.53M | -10.62M |
Net Income | -9.8M | -9.91M | -10.57M | -11.93M | -10.14M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 1.42M | 700k | 0 |
Operating Income | -47.95M | -49.97M | -63.01M | -58.06M | -43.57M |
Net Income | -46.97M | -49.85M | -63.66M | -58.51M | -42.21M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 70.22M | 74.76M | 65.95M | 59.15M | 49.16M |
Total Liabilities | 80.89M | 14.26M | 13.8M | 14.79M | 12.88M |
Total Equity | -10.67M | 60.5M | 52.15M | 44.36M | 36.29M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 41.92M | 41.29M | 54.25M | 77.88M | 59.15M |
Total Liabilities | 11.18M | 18.4M | 18.56M | 80.13M | 14.79M |
Total Equity | 30.74M | 22.89M | 35.69M | -2.25M | 44.36M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -6.57M | -15.77M | -26.26M | -33.04M | -9.78M |
Investing | -39k | -55k | -78k | -121k | -5k |
Financing | -432k | 13.44M | 15.58M | 16.39M | 305k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -34.19M | -35.37M | -54.1M | -47.01M | -33.04M |
Investing | -10.1M | 10.04M | 7.56M | -401k | -121k |
Financing | 82k | 30.89M | 62.69M | 79.94M | 16.39M |
Market Cap | 709.94M |
Price to Earnings Ratio | -16.35 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 15.56 |
Price to Book Ratio | 15.56 |
Dividend Yield | - |
Shares Outstanding | 54.99M |
Average Volume (1 week) | 339.23k |
Average Volume (1 Month) | 303.77k |
52 Week Change | 110.60% |
52 Week High | 14.96 |
52 Week Low | 3.78 |
Spread (Intraday) | 1.17 (8.59%) |
Company Name | Pulse Biosciences Inc |
Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
Website | https://www.pulsebiosciences.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions